ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 92618 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 92618; 2) Community: the network communities that were significantly associated with the response to NSC 92618; 3) Molecule: the relationships between components within communities and NSC 92618; 4) MDR: the compounds that were significantly associated with the NSC 92618.

NSC Compound Enrichment Correlation
NSC 346098 Null 0.0267520285931239 0.2795495
NSC 350629 2-Propen-1-one, 2-[(dimethylamino)methy]-1-(4- .beta.-D-glucopyranosyloxyphenyl)-, tetraacetate ester 0.0267520285931239 0.54278854
NSC 354051 LISCUNDITRIN 0.0267520285931239 0.42674709
NSC 355644 Anthrapyrazole derivative 0.0267520285931239 0.076690369
NSC 382032 Null 0.0267520285931239 0.17825378
NSC 601679 Null 0.0267520285931239 0.14237253
NSC 603084 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (E)- 0.0267520285931239 0.4458872
NSC 608984 Leucinostatine D 0.0267520285931239 0.10143402
NSC 616960 2[5H]-Furanone, 5-[(.beta.-D-glucopyranosyloxy)methyl]-,(S)- (9CI) 0.0267520285931239 0.41585962
NSC 618770 Piperidin-4-ol, N-ethyl-N-methyl-3-(1-oxo-3-phenyl-2-propen-1-yl)-4-(2-phenylethen-1-yl)-, (E,E)-, bromide 0.0267520285931239 0.48045565
Total:118  Current:71    [First] [Prev] [Next] [Last]